Work

Inhalable and Nasal Biologics: Analytical, Formulation, Development, and Regulatory Considerations

Year: 2025

Type: article

Source: Journal of Aerosol Medicine and Pulmonary Drug Delivery

DOI: 10.1089/jamp.2024.0058

Authors: David Cipolla, Christopher J. Gruenloh, Nani Kadrichu, Philip J. Kuehl, Lei Mao, Bing V. Li, Svetlana Lyapustina, Heidi M. Mansour, Franz-Josef K. Rehmann, Irene Rossi, Gur Jai Pal Singh, Julie D. Suman, Nurcin Ugur

Institutions: Insmed (United States), United States Food and Drug Administration, Center for Drug Evaluation and Research, Florida International University, AstraZeneca (Sweden), Harro Höfliger (Germany), Aalto University

Language: English

Topic: Inhalation and Respiratory Drug Delivery

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409281565

FWCI: 5.338

Cites: 61

Cited by: 9

Related to: 10